<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38892110</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Inflammation, Autoimmunity, and Infection in Fibromyalgia: A Narrative Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5922</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25115922</ELocationID><Abstract><AbstractText>Fibromyalgia (FM) is a chronic disease characterized by widespread musculoskeletal pain of unknown etiology. The condition is commonly associated with other symptoms, including fatigue, sleep disturbances, cognitive impairment, and depression. For this reason, FM is also referred to as FM syndrome. The nature of the pain is defined as nociplastic according to the latest international classification and is characterized by altered nervous sensitization both centrally and peripherally. Psychosocial conditions have traditionally been considered critical in the genesis of FM. However, recent studies in animal models and humans have provided new evidence in favor of an inflammatory and/or autoimmune pathogenesis. In support of this hypothesis are epidemiological data of an increased female prevalence, similar to that of autoimmune diseases, and the frequent association with immune-mediated inflammatory disorders. In addition, the observation of an increased incidence of this condition during long COVID revived the hypothesis of an infectious pathogenesis. This narrative review will, therefore, discuss the evidence supporting the immune-mediated pathogenesis of FM in light of the most current data available in the literature.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paroli</LastName><ForeName>Marino</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7919-9128</Identifier><AffiliationInfo><Affiliation>Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University di Roma, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gioia</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3559-2571</Identifier><AffiliationInfo><Affiliation>Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University di Roma, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Accapezzato</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0983-3610</Identifier><AffiliationInfo><Affiliation>Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University di Roma, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caccavale</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University di Roma, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="Y">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">fibromyalgia</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38892110</ArticleId><ArticleId IdType="pmc">PMC11172859</ArticleId><ArticleId IdType="doi">10.3390/ijms25115922</ArticleId><ArticleId IdType="pii">ijms25115922</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bair M.J., Krebs E.E. Fibromyalgia. Ann. Intern. Med. 2020;172:ITC33&#x2013;ITC48. doi: 10.7326/AITC202003030.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202003030</ArticleId><ArticleId IdType="pubmed">32120395</ArticleId></ArticleIdList></Reference><Reference><Citation>Varrassi G., Rekatsina M., Perrot S., Bouajina E., Paladini A., Coaccioli S., Narvaez Tamayo M.A., Sarzi Puttini P. Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus. 2023;15:e44852. doi: 10.7759/cureus.44852.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.44852</ArticleId><ArticleId IdType="pmc">PMC10560069</ArticleId><ArticleId IdType="pubmed">37809234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass C., Petrie K.J. New pain labels are unhelpful for patients and clinicians. J. Psychosom. Res. 2022;160:110960. doi: 10.1016/j.jpsychores.2022.110960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.110960</ArticleId><ArticleId IdType="pubmed">35752138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosek E., Cohen M., Baron R., Gebhart G.F., Mico J.A., Rice A.S.C., Rief W., Sluka A.K. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157:1382&#x2013;1386. doi: 10.1097/j.pain.0000000000000507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000507</ArticleId><ArticleId IdType="pubmed">26835783</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzi-Puttini P., Giorgi V., Marotto D., Atzeni F. Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment. Nat. Rev. Rheumatol. 2020;16:645&#x2013;660. doi: 10.1038/s41584-020-00506-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00506-w</ArticleId><ArticleId IdType="pubmed">33024295</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques A.P., Santo A., Berssaneti A.A., Matsutani L.A., Yuan S.L.K. Prevalence of fibromyalgia: Literature review update. Rev. Bras. Reumatol. Engl. Ed. 2017;57:356&#x2013;363. doi: 10.1016/j.rbre.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbre.2017.01.005</ArticleId><ArticleId IdType="pubmed">28743363</ArticleId></ArticleIdList></Reference><Reference><Citation>Treister-Goltzman Y., Peleg R. Fibromyalgia and mortality: A systematic review and meta-analysis. RMD Open. 2023;9:e003005. doi: 10.1136/rmdopen-2023-003005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2023-003005</ArticleId><ArticleId IdType="pmc">PMC10335452</ArticleId><ArticleId IdType="pubmed">37429737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakkaphan P., Smith J.G., Chana P., Tan H.L., Ravindranath P.T., Lambru G., Renton T. Temporomandibular Disorders and Fibromyalgia Prevalence: A Systematic Review and Meta-Analysis. J. Oral Facial Pain Headache. 2023;37:177&#x2013;193. doi: 10.11607/ofph.3260.</Citation><ArticleIdList><ArticleId IdType="doi">10.11607/ofph.3260</ArticleId><ArticleId IdType="pmc">PMC10664703</ArticleId><ArticleId IdType="pubmed">37975782</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugars Y., Berthelot J.M., Le Goff B., Darrieutort-Laffite C. Fibromyalgia and Associated Disorders: From Pain to Chronic Suffering, From Subjective Hypersensitivity to Hypersensitivity Syndrome. Front. Med. 2021;8:666914. doi: 10.3389/fmed.2021.666914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.666914</ArticleId><ArticleId IdType="pmc">PMC8316633</ArticleId><ArticleId IdType="pubmed">34336880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Jordan I., Jones C., Lawson P., Younger J.W. Abnormal immune system response in the brain of women with Fibromyalgia after experimental endotoxin challenge. Brain Behav. Immun. Health. 2023;30:100624. doi: 10.1016/j.bbih.2023.100624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100624</ArticleId><ArticleId IdType="pmc">PMC10126845</ArticleId><ArticleId IdType="pubmed">37114015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao M., Wang S., Han Y., Zhao H., Yin Y., Zhang Y., Zeng X. Micro-inflammation related gene signatures are associated with clinical features and immune status of fibromyalgia. J. Transl. Med. 2023;21:594. doi: 10.1186/s12967-023-04477-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04477-w</ArticleId><ArticleId IdType="pmc">PMC10478377</ArticleId><ArticleId IdType="pubmed">37670381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendieta D., De la Cruz-Aguilera D.L., Barrera-Villalpando M.I., Becerril-Villanueva E., Arreola R., Hernandez-Ferreira E., Perez-Tapia S.M., Perez-Sanchez G., Garces-Alvarez M.E., Aguirre-Cruz L., et al. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J. Neuroimmunol. 2016;290:22&#x2013;25. doi: 10.1016/j.jneuroim.2015.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.11.011</ArticleId><ArticleId IdType="pubmed">26711564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellergezen P., Alp A., Cavun S. Evaluation of the Relationship between Proinflammatory Cytokine Levels and Clinical Findings of Fibromyalgia Syndrome. Iran. J. Immunol. 2021;18:338&#x2013;345. doi: 10.22034/IJI.2021.90539.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/IJI.2021.90539.2013</ArticleId><ArticleId IdType="pubmed">34931619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation. 2012;19:343&#x2013;351. doi: 10.1159/000341664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341664</ArticleId><ArticleId IdType="pubmed">22986514</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura M., Targino R.A., Hsing W.T., Imamura S., Azevedo R.S., Boas L.S., Tozetto-Mendoza T.R., Alfieri F.M., Filippo T.R., Battistella L.R. Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin. Interv. Aging. 2014;9:939&#x2013;944. doi: 10.2147/CIA.S60330.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S60330</ArticleId><ArticleId IdType="pmc">PMC4061171</ArticleId><ArticleId IdType="pubmed">24959074</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace D.J., Gavin I.M., Karpenko O., Barkhordar F., Gillis B.S. Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: A potentially useful tool in differential diagnosis. Rheumatol. Int. 2015;35:991&#x2013;996. doi: 10.1007/s00296-014-3172-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-014-3172-2</ArticleId><ArticleId IdType="pmc">PMC4435905</ArticleId><ArticleId IdType="pubmed">25377646</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo M., Bianchi B., Salaffi F., Pellegrino G., Iannuccelli C., Giorgi V., Sarzi-Puttini P. Fibromyalgia: One year in review 2024. Clin. Exp. Rheumatol. 2024 doi: 10.55563/clinexprheumatol/mbyi1n.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/mbyi1n</ArticleId><ArticleId IdType="pubmed">38607678</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D., Sarzi-Puttini P., Pellegrino G., Shoenfeld Y. Is fibromyalgia an autoimmune disorder? Autoimmun. Rev. 2024;23:103424. doi: 10.1016/j.autrev.2023.103424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103424</ArticleId><ArticleId IdType="pubmed">37634681</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Rodriguez A., Rubio-Arias J.A., Ramos-Campo D.J., Reche-Garcia C., Leyva-Vela B., Nadal-Nicolas Y. Psychological and Sleep Effects of Tryptophan and Magnesium-Enriched Mediterranean Diet in Women with Fibromyalgia. Int. J. Environ. Res. Public Health. 2020;17:2227. doi: 10.3390/ijerph17072227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17072227</ArticleId><ArticleId IdType="pmc">PMC7178091</ArticleId><ArticleId IdType="pubmed">32224987</ArticleId></ArticleIdList></Reference><Reference><Citation>Alciati A., Cirillo M., Masala I.F., Sarzi-Puttini P., Atzeni F. Differences in depression, anxiety and stress disorders between fibromyalgia associated with rheumatoid arthritis and primary fibromyalgia. Stress Health. 2021;37:255&#x2013;262. doi: 10.1002/smi.2992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smi.2992</ArticleId><ArticleId IdType="pubmed">32991777</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzcharles M.A., Perrot S., Hauser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur. J. Pain. 2018;22:1565&#x2013;1576. doi: 10.1002/ejp.1252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1252</ArticleId><ArticleId IdType="pubmed">29802812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan C.M., Schrepf A., Ichesco E., Larkin T., Harte S.E., Harris R.E., Murray A.D., Waiter G.D., Clauw D.J., Basu N. Association of Inflammation with Pronociceptive Brain Connections in Rheumatoid Arthritis Patients with Concomitant Fibromyalgia. Arthritis Rheumatol. 2020;72:41&#x2013;46. doi: 10.1002/art.41069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41069</ArticleId><ArticleId IdType="pubmed">31379121</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffield S.J., Miller N., Zhao S., Goodson N.J. Concomitant fibromyalgia complicating chronic inflammatory arthritis: A systematic review and meta-analysis. Rheumatology. 2018;57:1453&#x2013;1460. doi: 10.1093/rheumatology/key112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key112</ArticleId><ArticleId IdType="pmc">PMC6055651</ArticleId><ArticleId IdType="pubmed">29788461</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane G.J., Barnish M.S., Pathan E., Martin K.R., Haywood K.L., Siebert S., Packham J., Atzeni F., Jones G.T. Co-Occurrence and Characteristics of Patients with Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register. Arthritis Rheumatol. 2017;69:2144&#x2013;2150. doi: 10.1002/art.40185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40185</ArticleId><ArticleId IdType="pubmed">28622461</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello N., Etcheto A., Beal C., Dougados M., Molto A. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res. Ther. 2016;18:42. doi: 10.1186/s13075-016-0943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-0943-z</ArticleId><ArticleId IdType="pmc">PMC4748456</ArticleId><ArticleId IdType="pubmed">26860612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wach J., Letroublon M.C., Coury F., Tebib J.G. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice. J. Rheumatol. 2016;43:2056&#x2013;2063. doi: 10.3899/jrheum.160104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.160104</ArticleId><ArticleId IdType="pubmed">27633820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent L., Vang D., Nguyen J., Gupta M., Luk K., Ericson M.E., Simone D.A., Gupta K. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood. 2013;122:1853&#x2013;1862. doi: 10.1182/blood-2013-04-498105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-04-498105</ArticleId><ArticleId IdType="pmc">PMC3772495</ArticleId><ArticleId IdType="pubmed">23775718</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi M., Zekavat O.R., Sharifzadeh S., Mousavizadeh K. Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray. Am. J. Hematol. 2006;81:809&#x2013;816. doi: 10.1002/ajh.20708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.20708</ArticleId><ArticleId IdType="pubmed">16941613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna T.J., Brown M.A. The role of IL-17-secreting mast cells in inflammatory joint disease. Nat. Rev. Rheumatol. 2013;9:375&#x2013;379. doi: 10.1038/nrrheum.2012.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2012.205</ArticleId><ArticleId IdType="pubmed">23229447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai K., Tsai M., Saito H., Galli S.J. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol. Rev. 2018;282:121&#x2013;150. doi: 10.1111/imr.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12634</ArticleId><ArticleId IdType="pmc">PMC5813811</ArticleId><ArticleId IdType="pubmed">29431212</ArticleId></ArticleIdList></Reference><Reference><Citation>Albertoni Giraldes A.L., Salomao R., Leal P.D., Brunialti M.K., Sakata R.K. Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study. Int. J. Rheum. Dis. 2016;19:946&#x2013;953. doi: 10.1111/1756-185X.12904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12904</ArticleId><ArticleId IdType="pubmed">27309886</ArticleId></ArticleIdList></Reference><Reference><Citation>Salemi S., Rethage J., Wollina U., Michel B.A., Gay R.E., Gay S., Sprott H. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J. Rheumatol. 2003;30:146&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12508404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Li F., Li W.W., Stary C., Clark J.D., Xu S., Xiong X. The inflammasome as a target for pain therapy. Br. J. Anaesth. 2016;117:693&#x2013;707. doi: 10.1093/bja/aew376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew376</ArticleId><ArticleId IdType="pmc">PMC5155560</ArticleId><ArticleId IdType="pubmed">27956668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhemer S.A., Desouky M.K., Abdelghany A.K., Ibrahim M.F.G. Stem cells therapeutic effect in a reserpine-induced fibromyalgia rat model: A possible NLRP3 inflammasome modulation with neurogenesis promotion in the cerebral cortex. Life Sci. 2023;325:121784. doi: 10.1016/j.lfs.2023.121784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2023.121784</ArticleId><ArticleId IdType="pubmed">37196857</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Carinci F., Caraffa A., Ronconi G., Lessiani G., Theoharides T.C. Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines. Med. Hypotheses. 2017;106:10&#x2013;14. doi: 10.1016/j.mehy.2017.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2017.06.018</ArticleId><ArticleId IdType="pubmed">28818263</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello C.A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol. Rev. 2018;281:8&#x2013;27. doi: 10.1111/imr.12621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12621</ArticleId><ArticleId IdType="pmc">PMC5756628</ArticleId><ArticleId IdType="pubmed">29247995</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope J.E., Goodwin J.L., Ouimet J.M., Krizova A., Laskin M. Infections are not increased in scleroderma compared to non-inflammatory musculoskeletal disorders prior to disease onset. Open Rheumatol. J. 2007;1:12&#x2013;17. doi: 10.2174/1874312900701010012.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874312900701010012</ArticleId><ArticleId IdType="pmc">PMC2581823</ArticleId><ArticleId IdType="pubmed">19088895</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco I., Beritze N., Arguelles M., Carcaba V., Fernandez F., Janciauskiene S., Oikonomopoulou K., de Serres F.J., Fernandez-Bustillo E., Hollenberg M.D. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin. Rheumatol. 2010;29:1403&#x2013;1412. doi: 10.1007/s10067-010-1474-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-010-1474-7</ArticleId><ArticleId IdType="pubmed">20428906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas H.J., Brauch C.M., Settas L., Theoharides T.C. Fibromyalgia--new concepts of pathogenesis and treatment. Int. J. Immunopathol. Pharmacol. 2006;19:5&#x2013;10. doi: 10.1177/205873920601900102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/205873920601900102</ArticleId><ArticleId IdType="pubmed">16569342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribatti D. The crucial role of mast cells in blood-brain barrier alterations. Exp. Cell Res. 2015;338:119&#x2013;125. doi: 10.1016/j.yexcr.2015.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.05.013</ArticleId><ArticleId IdType="pubmed">26004870</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilioni I., Russell I.J., Stewart J.M., Gleason R.M., Theoharides T.C. Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells. J. Pharmacol. Exp. Ther. 2016;356:664&#x2013;672. doi: 10.1124/jpet.115.230060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.115.230060</ArticleId><ArticleId IdType="pmc">PMC4767394</ArticleId><ArticleId IdType="pubmed">26763911</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Zhang B., Kempuraj D., Tagen M., Vasiadi M., Angelidou A., Alysandratos K.D., Kalogeromitros D., Asadi S., Stavrianeas N., et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc. Natl. Acad. Sci. USA. 2010;107:4448&#x2013;4453. doi: 10.1073/pnas.1000803107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000803107</ArticleId><ArticleId IdType="pmc">PMC2840132</ArticleId><ArticleId IdType="pubmed">20160089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang Y., Dong H., Xu Y., Zhang S. Induction of Microglial Activation by Mediators Released from Mast Cells. Cell Physiol. Biochem. 2016;38:1520&#x2013;1531. doi: 10.1159/000443093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443093</ArticleId><ArticleId IdType="pubmed">27050634</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaszczyk L., Maitre M., Leste-Lasserre T., Clark S., Cota D., Oliet S.H.R., Fenelon V.S. Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation. J. Neuroinflamm. 2018;15:349. doi: 10.1186/s12974-018-1378-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1378-z</ArticleId><ArticleId IdType="pmc">PMC6302506</ArticleId><ArticleId IdType="pubmed">30572902</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I., Ren H. Recent advances in our understanding of mast cell activation&#x2014;Or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 2019;15:639&#x2013;656. doi: 10.1080/1744666X.2019.1596800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType="pmc">PMC7003574</ArticleId><ArticleId IdType="pubmed">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl B., Vadlau Y., Zuchtriegel G., Nekolla K., Sharaf K., Gaertner F., Massberg S., Krombach F., Reichel C.A. Aged neutrophils contribute to the first line of defense in the acute inflammatory response. Blood. 2016;128:2327&#x2013;2337. doi: 10.1182/blood-2016-05-718999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-05-718999</ArticleId><ArticleId IdType="pmc">PMC5122310</ArticleId><ArticleId IdType="pubmed">27609642</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford J., Dale D.C., Lyman G.H. Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management. Cancer. 2004;100:228&#x2013;237. doi: 10.1002/cncr.11882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.11882</ArticleId><ArticleId IdType="pubmed">14716755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittner H.L., Hackel D., Yamdeu R.S., Mousa S.A., Stein C., Schafer M., Brack A. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium. Brain Behav. Immun. 2009;23:548&#x2013;557. doi: 10.1016/j.bbi.2009.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2009.02.007</ArticleId><ArticleId IdType="pubmed">19233260</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones H.R., Robb C.T., Perretti M., Rossi A.G. The role of neutrophils in inflammation resolution. Semin. Immunol. 2016;28:137&#x2013;145. doi: 10.1016/j.smim.2016.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2016.03.007</ArticleId><ArticleId IdType="pubmed">27021499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett G., Al-Rashed S., Hoult S.J.R., Brain D.S. Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain. 1998;77:315&#x2013;322. doi: 10.1016/S0304-3959(98)00114-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(98)00114-6</ArticleId><ArticleId IdType="pubmed">9808357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha T.M., Verri W.A., Jr., Schivo I.R., Napimoga M.H., Parada C.A., Poole S., Teixeira M.M., Ferreira S.H., Cunha F.Q. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J. Leukoc. Biol. 2008;83:824&#x2013;832. doi: 10.1189/jlb.0907654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0907654</ArticleId><ArticleId IdType="pubmed">18203872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bote M.E., Garcia J.J., Hinchado M.D., Ortega E. Fibromyalgia: Anti-inflammatory and stress responses after acute moderate exercise. PLoS ONE. 2013;8:e74524. doi: 10.1371/journal.pone.0074524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074524</ArticleId><ArticleId IdType="pmc">PMC3762808</ArticleId><ArticleId IdType="pubmed">24023948</ArticleId></ArticleIdList></Reference><Reference><Citation>Akturk S., Buyukavci R. Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clin. Rheumatol. 2017;36:1885&#x2013;1889. doi: 10.1007/s10067-017-3647-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-017-3647-0</ArticleId><ArticleId IdType="pubmed">28466420</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia J.J., Cidoncha A., Bote M.E., Hinchado M.D., Ortega E. Altered profile of chemokines in fibromyalgia patients. Ann. Clin. Biochem. 2014;51:576&#x2013;581. doi: 10.1177/0004563213506413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004563213506413</ArticleId><ArticleId IdType="pubmed">24106344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazzichi L., Rossi A., Massimetti G., Giannaccini G., Giuliano T., De Feo F., Ciapparelli A., Dell&#x2019;Osso L., Bombardieri S. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin. Exp. Rheumatol. 2007;25:225&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">17543146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K.T., Liao T.L., Chen Y.H., Chen D.Y., Lai K.L. Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients. Biomedicines. 2023;11:1774. doi: 10.3390/biomedicines11071774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071774</ArticleId><ArticleId IdType="pmc">PMC10376766</ArticleId><ArticleId IdType="pubmed">37509414</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin N., Owolabi S.A., Harty M.W., Papa E.F., Tracy T.F., Jr., Shaw S.K., Kim M., Saab C.Y. Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve. J. Neuroimmunol. 2007;184:164&#x2013;171. doi: 10.1016/j.jneuroim.2006.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.12.009</ArticleId><ArticleId IdType="pubmed">17275921</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaw Y.M., Cunningham C., Tierney A., Sivaguru M., Inoue M. Neutrophil-selective deletion of Cxcr2 protects against CNS neurodegeneration in a mouse model of multiple sclerosis. J. Neuroinflamm. 2020;17:49. doi: 10.1186/s12974-020-1730-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-1730-y</ArticleId><ArticleId IdType="pmc">PMC7001284</ArticleId><ArticleId IdType="pubmed">32019585</ArticleId></ArticleIdList></Reference><Reference><Citation>Caxaria S., Bharde S., Fuller A.M., Evans R., Thomas B., Celik P., Dell&#x2019;Accio F., Yona S., Gilroy D., Voisin M.B., et al. Neutrophils infiltrate sensory ganglia and mediate chronic widespread pain in fibromyalgia. Proc. Natl. Acad. Sci. USA. 2023;120:e2211631120. doi: 10.1073/pnas.2211631120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2211631120</ArticleId><ArticleId IdType="pmc">PMC10151464</ArticleId><ArticleId IdType="pubmed">37071676</ArticleId></ArticleIdList></Reference><Reference><Citation>Dempsey L.A. Neutrophils contribute to fibromyalgia. Nat. Immunol. 2023;24:886. doi: 10.1038/s41590-023-01532-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01532-y</ArticleId><ArticleId IdType="pubmed">37217706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch U.K., Kettenmann H. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007;10:1387&#x2013;1394. doi: 10.1038/nn1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1997</ArticleId><ArticleId IdType="pubmed">17965659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011;91:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiner P.S., Preusse C., Golebiewska A., Zinke J., Iriondo A., Muller A., Kaoma T., Filipski K., Muller-Eschner M., Bernatz S., et al. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathol. 2019;29:513&#x2013;529. doi: 10.1111/bpa.12690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12690</ArticleId><ArticleId IdType="pmc">PMC6849857</ArticleId><ArticleId IdType="pubmed">30506802</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco R., Fernandez-Suarez D. Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 2015;131:65&#x2013;86. doi: 10.1016/j.pneurobio.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.05.003</ArticleId><ArticleId IdType="pubmed">26067058</ArticleId></ArticleIdList></Reference><Reference><Citation>Domoto R., Sekiguchi F., Tsubota M., Kawabata A. Macrophage as a Peripheral Pain Regulator. Cells. 2021;10:1881. doi: 10.3390/cells10081881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081881</ArticleId><ArticleId IdType="pmc">PMC8392675</ArticleId><ArticleId IdType="pubmed">34440650</ArticleId></ArticleIdList></Reference><Reference><Citation>Komori T., Morikawa Y., Inada T., Hisaoka T., Senba E. Site-specific subtypes of macrophages recruited after peripheral nerve injury. NeuroReport. 2011;22:911&#x2013;917. doi: 10.1097/WNR.0b013e32834cd76a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0b013e32834cd76a</ArticleId><ArticleId IdType="pubmed">21979425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucic N., Racki V., Sverko R., Vidovic T., Grahovac I., Mrsic-Pelcic J. Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells. Int. J. Mol. Sci. 2021;22:8429. doi: 10.3390/ijms22168429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168429</ArticleId><ArticleId IdType="pmc">PMC8395119</ArticleId><ArticleId IdType="pubmed">34445130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgill J., McGee E., Menzies V. Unique cytokine signature in the plasma of patients with fibromyalgia. J. Immunol. Res. 2014;2014:938576. doi: 10.1155/2014/938576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/938576</ArticleId><ArticleId IdType="pmc">PMC3987983</ArticleId><ArticleId IdType="pubmed">24741634</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht D.S., Mainero C., Ichijo E., Ward N., Granziera C., Zurcher N.R., Akeju O., Bonnier G., Price J., Hooker J.M., et al. Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study. Neurology. 2019;92:e2038&#x2013;e2050. doi: 10.1212/WNL.0000000000007371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007371</ArticleId><ArticleId IdType="pmc">PMC6511078</ArticleId><ArticleId IdType="pubmed">30918090</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.R., Andriessen A.S., Chen G., Wang K., Jiang C., Maixner W., Ji R.R. Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain. Neurotherapeutics. 2020;17:846&#x2013;860. doi: 10.1007/s13311-020-00905-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-020-00905-7</ArticleId><ArticleId IdType="pmc">PMC7609632</ArticleId><ArticleId IdType="pubmed">32820378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankerd K., McDonough K.E., Wang J., Tang S.J., Chung J.M., La J.H. Postinjury stimulation triggers a transition to nociplastic pain in mice. Pain. 2022;163:461&#x2013;473. doi: 10.1097/j.pain.0000000000002366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002366</ArticleId><ArticleId IdType="pmc">PMC8669020</ArticleId><ArticleId IdType="pubmed">34285154</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Perez B., Bago-Mas A., Deulofeu M., Vela J.M., Merlos M., Verdu E., Boadas-Vaello P. Long-Lasting Nociplastic Pain Modulation by Repeated Administration of Sigma-1 Receptor Antagonist BD1063 in Fibromyalgia-like Mouse Models. Int. J. Mol. Sci. 2022;23:11933. doi: 10.3390/ijms231911933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911933</ArticleId><ArticleId IdType="pmc">PMC9569697</ArticleId><ArticleId IdType="pubmed">36233233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieseler-Frank J., Maier S.F., Watkins L.R. Glial activation and pathological pain. Neurochem. Int. 2004;45:389&#x2013;395. doi: 10.1016/j.neuint.2003.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2003.09.009</ArticleId><ArticleId IdType="pubmed">15145553</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger J.W., Zautra A.J., Cummins E.T. Effects of naltrexone on pain sensitivity and mood in fibromyalgia: No evidence for endogenous opioid pathophysiology. PLoS ONE. 2009;4:e5180. doi: 10.1371/journal.pone.0005180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005180</ArticleId><ArticleId IdType="pmc">PMC2664472</ArticleId><ArticleId IdType="pubmed">19365548</ArticleId></ArticleIdList></Reference><Reference><Citation>Merriwether E.N., Agalave N.M., Dailey D.L., Rakel B.A., Kolker S.J., Lenert M.E., Spagnola W.H., Lu Y., Geasland K.M., Allen L.H., et al. IL-5 mediates monocyte phenotype and pain outcomes in fibromyalgia. Pain. 2021;162:1468&#x2013;1482. doi: 10.1097/j.pain.0000000000002089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002089</ArticleId><ArticleId IdType="pmc">PMC7987864</ArticleId><ArticleId IdType="pubmed">33003107</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordaro M., Siracusa R., D&#x2019;Amico R., Genovese T., Franco G., Marino Y., Di Paola D., Cuzzocrea S., Impellizzeri D., Di Paola R., et al. Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia. Int. J. Mol. Sci. 2022;23:6139. doi: 10.3390/ijms23116139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23116139</ArticleId><ArticleId IdType="pmc">PMC9181785</ArticleId><ArticleId IdType="pubmed">35682817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Ness T.J., Younger J.W. Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial. J. Pain Res. 2021;14:189&#x2013;200. doi: 10.2147/JPR.S285609.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S285609</ArticleId><ArticleId IdType="pmc">PMC7851375</ArticleId><ArticleId IdType="pubmed">33542651</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331:44&#x2013;49. doi: 10.1126/science.1198687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1198687</ArticleId><ArticleId IdType="pmc">PMC3089969</ArticleId><ArticleId IdType="pubmed">21212348</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligiuri M.A. Human natural killer cells. Blood. 2008;112:461&#x2013;469. doi: 10.1182/blood-2007-09-077438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-09-077438</ArticleId><ArticleId IdType="pmc">PMC2481557</ArticleId><ArticleId IdType="pubmed">18650461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001;1:41&#x2013;49. doi: 10.1038/35095564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35095564</ArticleId><ArticleId IdType="pubmed">11905813</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher D.P., Walia D., Heller N.M. Suppression of Human Natural Killer Cells by Different Classes of Opioids. Anesth. Analg. 2019;128:1013&#x2013;1021. doi: 10.1213/ANE.0000000000004058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004058</ArticleId><ArticleId IdType="pmc">PMC6726115</ArticleId><ArticleId IdType="pubmed">30801358</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein T.K. The Role of Opioid Receptors in Immune System Function. Front. Immunol. 2019;10:2904. doi: 10.3389/fimmu.2019.02904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02904</ArticleId><ArticleId IdType="pmc">PMC6934131</ArticleId><ArticleId IdType="pubmed">31921165</ArticleId></ArticleIdList></Reference><Reference><Citation>Campana G., Sarti D., Spampinato S., Raffaeli W. Long-term intrathecal morphine and bupivacaine upregulate MOR gene expression in lymphocytes. Int. Immunopharmacol. 2010;10:1149&#x2013;1152. doi: 10.1016/j.intimp.2010.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2010.06.016</ArticleId><ArticleId IdType="pubmed">20609402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaveriaux-Ruff C., Kieffer B.L. Opioid receptor genes inactivated in mice: The highlights. Neuropeptides. 2002;36:62&#x2013;71. doi: 10.1054/npep.2002.0900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/npep.2002.0900</ArticleId><ArticleId IdType="pubmed">12359497</ArticleId></ArticleIdList></Reference><Reference><Citation>Brejchova J., Holan V., Svoboda P. Expression of Opioid Receptors in Cells of the Immune System. Int. J. Mol. Sci. 2020;22:315. doi: 10.3390/ijms22010315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010315</ArticleId><ArticleId IdType="pmc">PMC7795304</ArticleId><ArticleId IdType="pubmed">33396783</ArticleId></ArticleIdList></Reference><Reference><Citation>Plein L.M., Rittner H.L. Opioids and the immune system&#x2014;Friend or foe. Br. J. Pharmacol. 2018;175:2717&#x2013;2725. doi: 10.1111/bph.13750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13750</ArticleId><ArticleId IdType="pmc">PMC6016673</ArticleId><ArticleId IdType="pubmed">28213891</ArticleId></ArticleIdList></Reference><Reference><Citation>Malafoglia V., Ilari S., Gioia C., Vitiello L., Tenti M., Iannuccelli C., Cristiani C.M., Garofalo C., Passacatini L.C., Viglietto G., et al. An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor&#x2019;s Expression on NK Cells? Biomedicines. 2023;11:931. doi: 10.3390/biomedicines11030931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11030931</ArticleId><ArticleId IdType="pmc">PMC10046119</ArticleId><ArticleId IdType="pubmed">36979910</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma V., Drury G.L., Parisien M., Ozdag Acarli A.N., Al-Aubodah T.A., Nijnik A., Wen X., Tugarinov N., Verner M., Klares R., 3rd, et al. Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia. Pain. 2022;163:e821&#x2013;e836. doi: 10.1097/j.pain.0000000000002498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002498</ArticleId><ArticleId IdType="pmc">PMC8942876</ArticleId><ArticleId IdType="pubmed">34913882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.A., Edwards T.N., Liu A.W., Hirai T., Jones M.R., Wu J., Li Y., Zhang S., Ho J., Davis B.M., et al. Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity. Cell. 2019;178:919&#x2013;932.e914. doi: 10.1016/j.cell.2019.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.06.022</ArticleId><ArticleId IdType="pmc">PMC6788801</ArticleId><ArticleId IdType="pubmed">31353219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganor Y., Besser M., Ben-Zakay N., Unger T., Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J. Immunol. 2003;170:4362&#x2013;4372. doi: 10.4049/jimmunol.170.8.4362.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.8.4362</ArticleId><ArticleId IdType="pubmed">12682273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi Y., Kiguchi N., Fukazawa Y., Saika F., Maeda T., Kishioka S. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J. Biol. Chem. 2015;290:12603&#x2013;12613. doi: 10.1074/jbc.M115.636506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.636506</ArticleId><ArticleId IdType="pmc">PMC4432281</ArticleId><ArticleId IdType="pubmed">25787078</ArticleId></ArticleIdList></Reference><Reference><Citation>Draleau K., Maddula S., Slaiby A., Nutile-McMenemy N., De Leo J., Cao L. Phenotypic Identification of Spinal Cord-Infiltrating CD4(+) T Lymphocytes in a Murine Model of Neuropathic Pain. J. Pain Relief. 2014;(Suppl. S3):003. doi: 10.4172/2167-0846.S3-003.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2167-0846.S3-003</ArticleId><ArticleId IdType="pmc">PMC4136538</ArticleId><ArticleId IdType="pubmed">25143871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorge R.E., Mapplebeck J.C., Rosen S., Beggs S., Taves S., Alexander J.K., Martin L.J., Austin J.S., Sotocinal S.G., Chen D., et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat. Neurosci. 2015;18:1081&#x2013;1083. doi: 10.1038/nn.4053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4053</ArticleId><ArticleId IdType="pmc">PMC4772157</ArticleId><ArticleId IdType="pubmed">26120961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hader N., Rimon D., Kinarty A., Lahat N. Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. Arthritis Rheum. 1991;34:866&#x2013;872. doi: 10.1002/art.1780340712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780340712</ArticleId><ArticleId IdType="pubmed">1676263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernanz W., Valenzuela A., Quijada J., Garcia A., de la Iglesia J.L., Gutierrez A., Povedano J., Moreno I., Sanchez B. Lymphocyte subpopulations in patients with primary fibromyalgia. J. Rheumatol. 1994;21:2122&#x2013;2124.</Citation><ArticleIdList><ArticleId IdType="pubmed">7869321</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell I.J., Vipraio G.A., Michalek J.E., Craig F.E., Kang Y.K., Richards A.B. Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: Effects of low-dose, sublingual use of human interferon-alpha. J. Interferon Cytokine Res. 1999;19:969&#x2013;978. doi: 10.1089/107999099313523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999099313523</ArticleId><ArticleId IdType="pubmed">10476945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann I., Eisner C., Richter P., Huge V., Beyer A., Chouker A., Schelling G., Thiel M. Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients. Neuroimmunomodulation. 2007;14:272&#x2013;280. doi: 10.1159/000115041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000115041</ArticleId><ArticleId IdType="pubmed">18239379</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho L.S., Correa H., Silva G.C., Campos F.S., Baiao F.R., Ribeiro L.S., Faria A.M., d&#x2019;Avila Reis D. May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells? Clin. Exp. Immunol. 2008;154:346&#x2013;352. doi: 10.1111/j.1365-2249.2008.03787.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2008.03787.x</ArticleId><ArticleId IdType="pmc">PMC2633236</ArticleId><ArticleId IdType="pubmed">19037919</ArticleId></ArticleIdList></Reference><Reference><Citation>Guggino G., Schinocca C., Lo Pizzo M., Di Liberto D., Garbo D., Raimondo S., Alessandro R., Brighina F., Ruscitti P., Giacomelli R., et al. T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy. Clin. Exp. Rheumatol. 2019;37((Suppl. S116)):81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">30747094</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolcino M., Tinazzi E., Puccetti A., Lunardi C. Gene Expression Profiling in Fibromyalgia Indicates an Autoimmune Origin of the Disease and Opens New Avenues for Targeted Therapy. J. Clin. Med. 2020;9:1814. doi: 10.3390/jcm9061814.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061814</ArticleId><ArticleId IdType="pmc">PMC7356177</ArticleId><ArticleId IdType="pubmed">32532082</ArticleId></ArticleIdList></Reference><Reference><Citation>Katchan V., David P., Shoenfeld Y. Cannabinoids and autoimmune diseases: A systematic review. Autoimmun. Rev. 2016;15:513&#x2013;528. doi: 10.1016/j.autrev.2016.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.02.008</ArticleId><ArticleId IdType="pubmed">26876387</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz D., Katz I., Porat-Katz B.S., Shoenfeld Y. Medical cannabis: Another piece in the mosaic of autoimmunity? Clin. Pharmacol. Ther. 2017;101:230&#x2013;238. doi: 10.1002/cpt.568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.568</ArticleId><ArticleId IdType="pubmed">27859024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A., Churilov L.P., Shoenfeld Y. Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination? Int. J. Mol. Sci. 2019;20:5164. doi: 10.3390/ijms20205164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205164</ArticleId><ArticleId IdType="pmc">PMC6834318</ArticleId><ArticleId IdType="pubmed">31635218</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskila D., Atzeni F., Sarzi-Puttini P. Etiology of fibromyalgia: The possible role of infection and vaccination. Autoimmun. Rev. 2008;8:41&#x2013;43. doi: 10.1016/j.autrev.2008.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.07.023</ArticleId><ArticleId IdType="pubmed">18706528</ArticleId></ArticleIdList></Reference><Reference><Citation>Pridgen W.L., Duffy C., Gendreau J.F., Gendreau R.M. A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia. J. Pain Res. 2017;10:451&#x2013;460. doi: 10.2147/JPR.S127288.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S127288</ArticleId><ArticleId IdType="pmc">PMC5328426</ArticleId><ArticleId IdType="pubmed">28260944</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo T., Proudman S., Limaye V. Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population. Clin. Rheumatol. 2019;38:1271&#x2013;1276. doi: 10.1007/s10067-019-04447-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04447-y</ArticleId><ArticleId IdType="pubmed">30706290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Walitt B., Perrot S., Rasker J.J., Hauser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS ONE. 2018;13:e0203755. doi: 10.1371/journal.pone.0203755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0203755</ArticleId><ArticleId IdType="pmc">PMC6136749</ArticleId><ArticleId IdType="pubmed">30212526</ArticleId></ArticleIdList></Reference><Reference><Citation>Horven S., Stiles T.C., Holst A., Moen T. HLA antigens in primary fibromyalgia syndrome. J. Rheumatol. 1992;19:1269&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">1404164</ArticleId></ArticleIdList></Reference><Reference><Citation>Padgett D.A., Glaser R. How stress influences the immune response. Trends Immunol. 2003;24:444&#x2013;448. doi: 10.1016/s1471-4906(03)00173-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1471-4906(03)00173-x</ArticleId><ArticleId IdType="pubmed">12909458</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan K.Q., Li Y.Y., Wang H.L., Mao X.T., Guo J.X., Wang F., Huang L.J., Li Y.N., Ma X.Y., Gao Z.J., et al. Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior. Cell. 2019;179:864&#x2013;879.e819. doi: 10.1016/j.cell.2019.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.10.001</ArticleId><ArticleId IdType="pubmed">31675497</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E., Lowell J.A. Th17 cells in depression. Brain Behav. Immun. 2018;69:28&#x2013;34. doi: 10.1016/j.bbi.2017.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.08.001</ArticleId><ArticleId IdType="pmc">PMC5797502</ArticleId><ArticleId IdType="pubmed">28779999</ArticleId></ArticleIdList></Reference><Reference><Citation>Steimer T. Animal models of anxiety disorders in rats and mice: Some conceptual issues. Dialogues Clin. Neurosci. 2011;13:495&#x2013;506. doi: 10.31887/DCNS.2011.13.4/tsteimer.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2011.13.4/tsteimer</ArticleId><ArticleId IdType="pmc">PMC3263396</ArticleId><ArticleId IdType="pubmed">22275854</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso M., Kempter E., Langgartner D., Gross P., Reber S.O. Inducing a stressed phenotype in healthy recipient mice by adoptively transferring CD4+ lymphocytes from mice undergoing chronic psychosocial stress. Psychoneuroendocrinology. 2020;122:104898. doi: 10.1016/j.psyneuen.2020.104898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2020.104898</ArticleId><ArticleId IdType="pubmed">33126029</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark S.M., Michael K.C., Klaus J., Mert A., Romano-Verthelyi A., Sand J., Tonelli L.H. Dissociation between sickness behavior and emotionality during lipopolysaccharide challenge in lymphocyte deficient Rag2&#x2212;/&#x2212; mice. Behav. Brain Res. 2015;278:74&#x2013;82. doi: 10.1016/j.bbr.2014.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2014.09.030</ArticleId><ArticleId IdType="pmc">PMC4369474</ArticleId><ArticleId IdType="pubmed">25257108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattazzi L., Piras G., Ono M., Deacon R., Pariante C.M., D&#x2019;Acquisto F. CD4+ but not CD8+ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice. Transl. Psychiatry. 2013;3:e280. doi: 10.1038/tp.2013.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2013.54</ArticleId><ArticleId IdType="pmc">PMC3731786</ArticleId><ArticleId IdType="pubmed">23838891</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyajima M., Zhang B., Sugiura Y., Sonomura K., Guerrini M.M., Tsutsui Y., Maruya M., Vogelzang A., Chamoto K., Honda K., et al. Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior. Nat. Immunol. 2017;18:1342&#x2013;1352. doi: 10.1038/ni.3867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3867</ArticleId><ArticleId IdType="pubmed">29058703</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Li Y., Wang F., Huang T., Fan K., Zhang Y., Zhong J., Cao Q., Chao T., Jia J., et al. Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability. Nat. Commun. 2017;8:1805. doi: 10.1038/s41467-017-01919-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01919-0</ArticleId><ArticleId IdType="pmc">PMC5703766</ArticleId><ArticleId IdType="pubmed">29180626</ArticleId></ArticleIdList></Reference><Reference><Citation>Buccione C., Fragale A., Polverino F., Ziccheddu G., Arico E., Belardelli F., Proietti E., Battistini A., Moschella F. Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide. Int. J. Cancer. 2018;142:976&#x2013;987. doi: 10.1002/ijc.31083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.31083</ArticleId><ArticleId IdType="pubmed">28975621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenert M.E., Szabo-Pardi T.A., Burton M.D. Regulatory T-cells and IL-5 mediate pain outcomes in a preclinical model of chronic muscle pain. Mol. Pain. 2023;19:17448069221110691. doi: 10.1177/17448069221110691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17448069221110691</ArticleId><ArticleId IdType="pmc">PMC9926397</ArticleId><ArticleId IdType="pubmed">35712872</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaeli W., Malafoglia V., Bonci A., Tenti M., Ilari S., Gremigni P., Iannuccelli C., Gioia C., Di Franco M., Mollace V., et al. Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases. Int. J. Mol. Sci. 2020;21:1499. doi: 10.3390/ijms21041499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041499</ArticleId><ArticleId IdType="pmc">PMC7073128</ArticleId><ArticleId IdType="pubmed">32098316</ArticleId></ArticleIdList></Reference><Reference><Citation>Fineschi S., Klar J., Gustafsson K.A., Jonsson K., Karlsson B., Dahl N. Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals with Fibromyalgia. Front. Immunol. 2022;13:874490. doi: 10.3389/fimmu.2022.874490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.874490</ArticleId><ArticleId IdType="pmc">PMC9177944</ArticleId><ArticleId IdType="pubmed">35693781</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel A., Krock E., Gentry C., Israel M.R., Jurczak A., Urbina C.M., Sandor K., Vastani N., Maurer M., Cuhadar U., et al. Passive transfer of fibromyalgia symptoms from patients to mice. J. Clin. Investig. 2021;131:e144201. doi: 10.1172/JCI144201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144201</ArticleId><ArticleId IdType="pmc">PMC8245181</ArticleId><ArticleId IdType="pubmed">34196305</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanton S., Menezes J., Krock E., Sandstrom A., Tour J., Sandor K., Jurczak A., Hunt M., Baharpoor A., Kadetoff D., et al. Anti-satellite glia cell IgG antibodies in fibromyalgia patients are related to symptom severity and to metabolite concentrations in thalamus and rostral anterior cingulate cortex. Brain Behav. Immun. 2023;114:371&#x2013;382. doi: 10.1016/j.bbi.2023.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.09.003</ArticleId><ArticleId IdType="pubmed">37683961</ArticleId></ArticleIdList></Reference><Reference><Citation>Krock E., Morado-Urbina C.E., Menezes J., Hunt M.A., Sandstrom A., Kadetoff D., Tour J., Verma V., Kultima K., Haglund L., et al. Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms. Pain. 2023;164:1828&#x2013;1840. doi: 10.1097/j.pain.0000000000002881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002881</ArticleId><ArticleId IdType="pmc">PMC10348624</ArticleId><ArticleId IdType="pubmed">36943275</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel A., Andersson D., Shoenfeld Y. The biology of symptom-based disorders&#x2014;Time to act. Autoimmun. Rev. 2023;22:103218. doi: 10.1016/j.autrev.2022.103218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103218</ArticleId><ArticleId IdType="pubmed">36280093</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A.M., Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun. Rev. 2023;22:103230. doi: 10.1016/j.autrev.2022.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103230</ArticleId><ArticleId IdType="pubmed">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J., Vincent A., Cha S.S., Luedtke C.A., Kim C.H., Oh T.H. Physical Trauma and Infection as Precipitating Factors in Patients with Fibromyalgia. Am. J. Phys. Med. Rehabil. 2015;94:1075&#x2013;1082. doi: 10.1097/PHM.0000000000000300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000000300</ArticleId><ArticleId IdType="pubmed">25888651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera J., de Diego A., Trinchet M., Garcia Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br. J. Rheumatol. 1997;36:981&#x2013;985. doi: 10.1093/rheumatology/36.9.981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/36.9.981</ArticleId><ArticleId IdType="pubmed">9376995</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskila D., Shnaider A., Neumann L., Zilberman D., Hilzenrat N., Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch. Intern. Med. 1997;157:2497&#x2013;2500. doi: 10.1001/archinte.1997.00440420129014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1997.00440420129014</ArticleId><ArticleId IdType="pubmed">9385302</ArticleId></ArticleIdList></Reference><Reference><Citation>Poynard T., Cacoub P., Ratziu V., Myers R.P., Dezailles M.H., Mercadier A., Ghillani P., Charlotte F., Piette J.C., Moussalli J., et al. Fatigue in patients with chronic hepatitis C. J. Viral Hepat. 2002;9:295&#x2013;303. doi: 10.1046/j.1365-2893.2002.00364.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2893.2002.00364.x</ArticleId><ArticleId IdType="pubmed">12081607</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskila D., Gladman D.D., Langevitz P., Urowitz S., Smythe H.A. Fibromyalgia in human immunodeficiency virus infection. J. Rheumatol. 1990;17:1202&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">2290162</ArticleId></ArticleIdList></Reference><Reference><Citation>Simms R.W., Zerbini C.A., Ferrante N., Anthony J., Felson D.T., Craven D.E. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team. Am. J. Med. 1992;92:368&#x2013;374. doi: 10.1016/0002-9343(92)90266-e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(92)90266-e</ArticleId><ArticleId IdType="pubmed">1558083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal L.H. Summary of the first 100 patients seen at a Lyme disease referral center. Am. J. Med. 1990;88:577&#x2013;581. doi: 10.1016/0002-9343(90)90520-n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(90)90520-n</ArticleId><ArticleId IdType="pubmed">2346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinerman H., Steere A.C. Lyme disease associated with fibromyalgia. Ann. Intern. Med. 1992;117:281&#x2013;285. doi: 10.7326/0003-4819-117-4-281.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-117-4-281</ArticleId><ArticleId IdType="pubmed">1637022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R.M., Jones J., Turk D.C., Russell I.J., Matallana L. An internet survey of 2596 people with fibromyalgia. BMC Musculoskelet. Disord. 2007;8:27. doi: 10.1186/1471-2474-8-27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-8-27</ArticleId><ArticleId IdType="pmc">PMC1829161</ArticleId><ArticleId IdType="pubmed">17349056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.Y., Annamalai C., Rao S.S.C. Post-Infectious Irritable Bowel Syndrome. Curr. Gastroenterol. Rep. 2017;19:56. doi: 10.1007/s11894-017-0595-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-017-0595-4</ArticleId><ArticleId IdType="pubmed">28948467</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellicano R., Savi L., De Martino P., Morgando A., Astegiano M., Pinessi L., Rizzetto M. Helicobacter pylori and headache: A minireview. Minerva Med. 2007;98:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17372580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhu Z., Liu D., Mi Z., Tao H., Fan H. Blood transcriptome and machine learning identified the crosstalk between COVID-19 and fibromyalgia: A preliminary study. Clin. Exp. Rheumatol. 2023;41:1262&#x2013;1274. doi: 10.55563/clinexprheumatol/tz9i6y.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/tz9i6y</ArticleId><ArticleId IdType="pubmed">36762746</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Felten R., Gallais F., Nazon C., Chatelus E., Pijnenburg L., Mengin A., Gras A., Vidailhet P., Arnould-Michel R., et al. Refining &#x201c;Long-COVID&#x201d; by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan M., Dvir A., Zaidenstein R., Keller M., Kagansky D., Hochman C., Koren R. Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients. Int. J. Gen. Med. 2021;14:4829&#x2013;4836. doi: 10.2147/IJGM.S323316.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S323316</ArticleId><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F., Ciaffi J., Mancarella L., Lisi L., Brusi V., Cavallari C., D&#x2019;Onghia M., Mari A., Borlandelli E., Faranda Cordella J., et al. Fibromyalgia: A new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7:e001735. doi: 10.1136/rmdopen-2021-001735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Cancela-Cilleruelo I., Moro-Lopez-Menchero P., Rodriguez-Jimenez J., Pellicer-Valero O.J., Martin-Guerrero J.D., Arendt-Nielsen L. Exploring the trajectory curve of long-term musculoskeletal post-COVID pain symptoms in hospitalized COVID-19 survivors: A multicenter study. Pain. 2023;164:413&#x2013;420. doi: 10.1097/j.pain.0000000000002718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002718</ArticleId><ArticleId IdType="pubmed">35930390</ArticleId></ArticleIdList></Reference><Reference><Citation>Widyadharma I.P.E., Dewi P.R., Wijayanti I.A.S., Utami D.K.I. Pain related viral infections: A literature review. Egypt. J. Neurol. Psychiatry Neurosurg. 2020;56:105. doi: 10.1186/s41983-020-00238-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-020-00238-4</ArticleId><ArticleId IdType="pmc">PMC7610167</ArticleId><ArticleId IdType="pubmed">33169060</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M., Nijs J., Hermans L., Goubert D., Calders P. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: Peripheral and central mechanisms as therapeutic targets? Expert. Opin. Ther. Targets. 2013;17:1081&#x2013;1089. doi: 10.1517/14728222.2013.818657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2013.818657</ArticleId><ArticleId IdType="pubmed">23834645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S., McPhail M.J., Singh K.K., Mujib S., Trovato F.M., Napoli S., Agarwal K. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am. J. Physiol. Cell Physiol. 2021;320:C57&#x2013;C65. doi: 10.1152/ajpcell.00426.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D.J., Calabrese L. Rheumatology and Long COVID: Lessons from the study of fibromyalgia. Ann. Rheum. Dis. 2024;83:136&#x2013;138. doi: 10.1136/ard-2023-224250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2023-224250</ArticleId><ArticleId IdType="pmc">PMC10850638</ArticleId><ArticleId IdType="pubmed">37230736</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A., Hunt B., Stegemann M., Rochwerg B., Lamontagne F., Siemieniuk R.A., Agoritsas T., Askie L., Lytvyn L., Leo Y.S., et al. A living WHO guideline on drugs for COVID-19. BMJ. 2020;370:m3379. doi: 10.1136/bmj.m3379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3379</ArticleId><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bath P., Algert C., Chapman N., Neal B., Group P.C. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35:622&#x2013;626. doi: 10.1161/01.STR.0000116105.26237.EC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000116105.26237.EC</ArticleId><ArticleId IdType="pubmed">14976328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ege F., Isik R. A Comparative Assessment of the Inflammatory Markers in Patients with Fibromyalgia under Duloxetine Treatment. Front. Biosci. 2023;28:161. doi: 10.31083/j.fbl2808161.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2808161</ArticleId><ArticleId IdType="pubmed">37664936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellergezen P., Alp A., Cavun S., Celebi M., Macunluoglu A.C. Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome. Arch. Rheumatol. 2023;38:307&#x2013;314. doi: 10.46497/ArchRheumatol.2023.9517.</Citation><ArticleIdList><ArticleId IdType="doi">10.46497/ArchRheumatol.2023.9517</ArticleId><ArticleId IdType="pmc">PMC10481681</ArticleId><ArticleId IdType="pubmed">37680505</ArticleId></ArticleIdList></Reference><Reference><Citation>Suso-Marti L., Nunez-Cortes R., Sanchez-Sabater A., Garrigos-Pedron M., Ferrer-Sargues F.J., Lopez-Bueno R., Calatayud J. Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis. Semin. Arthritis Rheum. 2024;65:152377. doi: 10.1016/j.semarthrit.2024.152377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2024.152377</ArticleId><ArticleId IdType="pubmed">38244445</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Rodriguez L., Borras X., Feliu-Soler A., Perez-Aranda A., Rozadilla-Sacanell A., Montero-Marin J., Maes M., Luciano J.V. Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): A randomized, controlled clinical trial. Brain Behav. Immun. 2019;80:109&#x2013;119. doi: 10.1016/j.bbi.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.02.030</ArticleId><ArticleId IdType="pubmed">30818032</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Rodriguez A., Leyva-Vela B., Martinez-Garcia A., Nadal-Nicolas Y. Effects of lacto-vegetarian diet and stabilization core exercises on body composition and pain in women with fibromyalgia: Randomized controlled trial. Nutr. Hosp. 2018;35:392&#x2013;399. doi: 10.20960/nh.1341.</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.1341</ArticleId><ArticleId IdType="pubmed">29756974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadal-Nicolas Y., Rubio-Arias J.A., Martinez-Olcina M., Reche-Garcia C., Hernandez-Garcia M., Martinez-Rodriguez A. Effects of Manual Therapy on Fatigue, Pain, and Psychological Aspects in Women with Fibromyalgia. Int. J. Environ. Res. Public Health. 2020;17:4611. doi: 10.3390/ijerph17124611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17124611</ArticleId><ArticleId IdType="pmc">PMC7345776</ArticleId><ArticleId IdType="pubmed">32604939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>